Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy have?
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy has 6,091 citations in the OpenAlex counts ScholarIQ stores.
When was Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy published?
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy has 2019 year in the ScholarIQ index.
What is the open-access status of Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy?
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy has bronze oa status in the ScholarIQ index.
What is the DOI of Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy?
The DOI for Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy is on the source record.
What is the PMID of Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy?
The PMID for Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy is on the source record.
What is the OpenAlex record for Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy?
The OpenAlex for Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy is on the source record.